The analysis was also performed considering the other available clinical data, observing a significant increase in circCDYL levels in ERα‐negative non‐invasive BC and in samples from patients with a complete tumor remission (Figure 1D,E and Table S1D). This evidence concerns the gene ESR1 and breast cancer.